Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  SHANGHAI STOCK EXCHANGE  >  Guangzhou Baiyunshan Phrmcl Hldgs Co Ltd    600332   CNE000001733

GUANGZHOU BAIYUNSHAN PHRMCL HLDGS CO LTD (600332)
My previous session
Most popular
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shanghai Stock Exchange
12/12/2018 12/13/2018 12/14/2018 12/17/2018 12/18/2018 Date
37.78(c) 38.17(c) 36.99(c) 36.55(c) 36.21 Last
6 507 584 9 307 810 11 973 920 7 775 993 6 945 609 Volume
-0.26% +1.03% -3.09% -1.19% -0.93% Change
More quotes
Financials (CNY)
Sales 2018 33 929 M
EBIT 2018 3 135 M
Net income 2018 3 759 M
Finance 2018 8 232 M
Yield 2018 1,51%
Sales 2019 45 921 M
EBIT 2019 3 693 M
Net income 2019 3 559 M
Finance 2019 6 974 M
Yield 2019 1,46%
P/E ratio 2018 17,09
P/E ratio 2019 17,65
EV / Sales2018 2,54x
EV / Sales2019 1,90x
Capitalization 94 419 M
More Financials
Company
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited is engaged in the pharmaceutical and healthcare industry. The Company's segments are Great Southern TCM, Great Commerce, Great Health and Great Medical Care. The Company's Great South TCM includes research, development, manufacturing and... 
Sector
Pharmaceuticals
Calendar
03/15Earnings Release
More about the company
Surperformance© ratings of Guangzhou Baiyunshan Phrmc
Trading Rating : Investor Rating :
More Ratings
Latest news on GUANGZHOU BAIYUNSHAN PHRMC
08/23GUANGZHOU BAIYUNSHAN PHRMCL HLDGS : Baiyunshan interim net up 126% to RMB2.6b; n..
AQ
07/12GUANGZHOU BAIYUNSHAN PHARMACEUTICAL : Ex-dividend day for final dividend
FA
04/27GUANGZHOU BAIYUNSHAN PHRMCL HLDGS : Baiyunshan 1Q net profit up 87% to Rmb905m
AQ
03/16GUANGZHOU BAIYUNSHAN PHRMCL HLDGS : Baiyunshan year net up 36.7% to Rmb2.06bn; d..
AQ
03/13GUANGZHOU BAIYUNSHAN PHRMCL HLDGS CO : annual earnings release
01/08GUANGZHOU BAIYUNSHAN PHRMCL HLDGS : Baiyunshan Pharma resumes A shares trading
AQ
2017GUANGZHOU BAIYUNSHAN PHARMACEUTICAL : Annual Report
CO
2017GUANGZHOU BAIYUNSHAN PHRMCL HLDGS : Baiyunshan to add stake in pharma products r..
AQ
2017GUANGZHOU BAIYUNSHAN PHRMCL HLDGS CO : Ex-dividend day for final dividend
FA
2016GUANGZHOU BAIYUNSHAN PHRMCL HLDGS CO : Ex-dividend day for extraordinary dividen..
FA
More news
Analyst Recommendations on GUANGZHOU BAIYUNSHAN PHRMC
More recommendations
Sector news : Pharmaceuticals - NEC
09:55pPATRICK THOMAS : FTC Approves Teva Petition to Give Pfizer More Time to Sell Dru..
DJ
07:15pLONDON STOCK EXCHANGE : Oil slide and growth worries smother FTSE 100 while mid-..
RE
05:35pBig Pharma Wins Drug Approval in China Ahead of West for First Time -- Update
DJ
04:41pSHIRE : Elliott Capital Advisors, L.P Elliott Capital -2-
DJ
04:41pELLIOTT CAPITAL ADVISORS, L.P ELLIOT : Form 8.3 - Shire Plc
DJ
More sector news : Pharmaceuticals - NEC
Chart GUANGZHOU BAIYUNSHAN PHRMCL HLDGS CO LTD
Duration : Period :
Guangzhou Baiyunshan Phrmcl Hldgs Co Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GUANGZHOU BAIYUNSHAN PHRMC
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 4
Average target price 39,7  CNY
Spread / Average Target 8,5%
EPS Revisions
Managers
NameTitle
Hong Li General Manager & Director
Chu Yuan Li Chairman
Jia Xiong Xian Chairman-Supervisory Board
Hin Wing Wong Independent Non-Executive Director
Chang Hai Wu Director & Deputy General Manager
Sector and Competitors
1st jan.Capitalization (M$)
GUANGZHOU BAIYUNSHAN PHRMCL HLDGS CO LTD13.72%13 752
JOHNSON & JOHNSON-7.57%356 703
PFIZER20.93%254 040
NOVARTIS4.10%223 295
ROCHE HOLDING LTD.0.69%216 307
MERCK AND COMPANY33.69%198 877